This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (52)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Guy A. Settipane, MD; Donald E. Klein, MD; George K. Boyd, MD; Jorge H. Sturam, MD; Henry B. Freye, MD; Joel K. Weltman, MD, PhD

JAMA. 1979;241(8):811-813.

Abstract
The frequency of adverse reactions (dermatitis, myositis, and gastroenteritis) to cromolyn sodium in asthmatic patients was 2% (8/375). Reactions were non-life-threatening and completely reversible. Immunologic evaluations, including skin and serum tests for immediate and delayed reactivity, all were negative. Adverse reactions to cromolyn do not appear to be based on an immunologic mechanism. Cromolyn appears to be a safe drug for the treatment of asthma.

(JAMA 241:811-813, 1979)

Author Affiliations
From the Division of Allergy, Department of Medicine and Pediatrics, Rhode Island Hospital, and the Program in Medicine, Brown University, Providence, RI.

Footnotes
Reprint requests to Division of Allergy, Rhode Island Hospital, Providence, RI 02902 (Dr Settipane).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Asthma
Lemanske and Busse
JAMA 1997;278:1855-1873.
ABSTRACT  

Adverse Reactions to Cromolyn Sodium: Patient Report and Review of the Literature
Lester and Bratton
CLIN PEDIATR 1997;36:707-710.
 

Drug-Induced Esophagitis-Reply
Spera and Amendola
JAMA 1985;254:508-508.
ABSTRACT  

Acute Chemotic Reaction to Cromolyn
Ostler
Arch Ophthalmol 1982;100:412-413.
ABSTRACT